Toll Free: 1-888-928-9744

Zambon Company S.p.A. - Product Pipeline Review - 2014

Published: Nov, 2014 | Pages: 41 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Zambon Company S.p.A. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Zambon Company S.p.A. - Product Pipeline Review - 2014', provides an overview of the Zambon Company S.p.A.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Zambon Company S.p.A.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Zambon Company S.p.A. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Zambon Company S.p.A.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Zambon Company S.p.A.'s pipeline products

Reasons to buy

- Evaluate Zambon Company S.p.A.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Zambon Company S.p.A. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Zambon Company S.p.A.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Zambon Company S.p.A. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Zambon Company S.p.A.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Zambon Company S.p.A. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Zambon Company S.p.A. Snapshot 5
Zambon Company S.p.A. Overview 5
Key Information 5
Key Facts 5
Zambon Company S.p.A. - Research and Development Overview 6
Key Therapeutic Areas 6
Zambon Company S.p.A. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Partnered Products 10
Partnered Products/Combination Treatment Modalities 11
Zambon Company S.p.A. - Pipeline Products Glance 12
Zambon Company S.p.A. - Late Stage Pipeline Products 12
Pre-Registration Products/Combination Treatment Modalities 12
Zambon Company S.p.A. - Early Stage Pipeline Products 13
Discovery Products/Combination Treatment Modalities 13
Zambon Company S.p.A. - Unknown Stage Pipeline Products 14
Unknown Products/Combination Treatment Modalities 14
Zambon Company S.p.A. - Drug Profiles 15
safinamide 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
ZP-031 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
ZP-037 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
ZP-040 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
ZP-042 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
ZP-049 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
ZP-003 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
ZP-006 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
ZP-008 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
ZP-044 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Zambon Company S.p.A. - Pipeline Analysis 27
Zambon Company S.p.A. - Pipeline Products by Target 27
Zambon Company S.p.A. - Pipeline Products by Route of Administration 28
Zambon Company S.p.A. - Pipeline Products by Molecule Type 29
Zambon Company S.p.A. - Pipeline Products by Mechanism of Action 30
Zambon Company S.p.A. - Recent Pipeline Updates 31
Zambon Company S.p.A. - Dormant Projects 34
Zambon Company S.p.A. - Company Statement 35
Zambon Company S.p.A. - Locations And Subsidiaries 37
Head Office 37
Other Locations & Subsidiaries 37
Appendix 40
Methodology 40
Coverage 40
Secondary Research 40
Primary Research 40
Expert Panel Validation 40
Contact Us 41
Disclaimer 41
List of Tables
Zambon Company S.p.A., Key Information 5
Zambon Company S.p.A., Key Facts 5
Zambon Company S.p.A. - Pipeline by Indication, 2014 7
Zambon Company S.p.A. - Pipeline by Stage of Development, 2014 8
Zambon Company S.p.A. - Monotherapy Products in Pipeline, 2014 9
Zambon Company S.p.A. - Partnered Products in Pipeline, 2014 10
Zambon Company S.p.A. - Partnered Products/ Combination Treatment Modalities, 2014 11
Zambon Company S.p.A. - Pre-Registration, 2014 12
Zambon Company S.p.A. - Discovery, 2014 13
Zambon Company S.p.A. - Unknown, 2014 14
Zambon Company S.p.A. - Pipeline by Target, 2014 27
Zambon Company S.p.A. - Pipeline by Route of Administration, 2014 28
Zambon Company S.p.A. - Pipeline by Molecule Type, 2014 29
Zambon Company S.p.A. - Pipeline Products by Mechanism of Action, 2014 30
Zambon Company S.p.A. - Recent Pipeline Updates, 2014 31
Zambon Company S.p.A. - Dormant Developmental Projects,2014 34
Zambon Company S.p.A., Other Locations 37
Zambon Company S.p.A., Subsidiaries 38 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify